1. Home
  2. CGEN vs DCGO Comparison

CGEN vs DCGO Comparison

Compare CGEN & DCGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEN
  • DCGO
  • Stock Information
  • Founded
  • CGEN 1993
  • DCGO 2015
  • Country
  • CGEN Israel
  • DCGO United States
  • Employees
  • CGEN N/A
  • DCGO N/A
  • Industry
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • DCGO Managed Health Care
  • Sector
  • CGEN Health Care
  • DCGO Health Care
  • Exchange
  • CGEN Nasdaq
  • DCGO Nasdaq
  • Market Cap
  • CGEN 125.3M
  • DCGO 136.0M
  • IPO Year
  • CGEN 2000
  • DCGO N/A
  • Fundamental
  • Price
  • CGEN $1.58
  • DCGO $1.11
  • Analyst Decision
  • CGEN
  • DCGO Strong Buy
  • Analyst Count
  • CGEN 0
  • DCGO 3
  • Target Price
  • CGEN N/A
  • DCGO $3.37
  • AVG Volume (30 Days)
  • CGEN 522.7K
  • DCGO 4.1M
  • Earning Date
  • CGEN 11-10-2025
  • DCGO 11-10-2025
  • Dividend Yield
  • CGEN N/A
  • DCGO N/A
  • EPS Growth
  • CGEN N/A
  • DCGO N/A
  • EPS
  • CGEN N/A
  • DCGO N/A
  • Revenue
  • CGEN $22,144,000.00
  • DCGO $435,968,564.00
  • Revenue This Year
  • CGEN N/A
  • DCGO N/A
  • Revenue Next Year
  • CGEN $208.08
  • DCGO N/A
  • P/E Ratio
  • CGEN N/A
  • DCGO N/A
  • Revenue Growth
  • CGEN N/A
  • DCGO N/A
  • 52 Week Low
  • CGEN $1.13
  • DCGO $1.01
  • 52 Week High
  • CGEN $2.66
  • DCGO $5.68
  • Technical
  • Relative Strength Index (RSI)
  • CGEN 44.43
  • DCGO 43.98
  • Support Level
  • CGEN $1.61
  • DCGO $1.01
  • Resistance Level
  • CGEN $1.80
  • DCGO $1.09
  • Average True Range (ATR)
  • CGEN 0.11
  • DCGO 0.11
  • MACD
  • CGEN -0.03
  • DCGO -0.00
  • Stochastic Oscillator
  • CGEN 19.35
  • DCGO 15.63

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About DCGO DocGo Inc.

DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.

Share on Social Networks: